Journal article
Comparison of activities of broad-spectrum beta-lactam compounds against 1,128 gram-positive cocci recently isolated in cancer treatment centers
Antimicrobial agents and chemotherapy, Vol.43(4), pp.940-943
04/1999
DOI: 10.1128/AAC.43.4.940
PMCID: PMC89230
PMID: 10103204
Abstract
We report the in vitro activities of broad-spectrum beta-lactam antimicrobials tested against 1,128 gram-positive pathogens recently isolated from cancer patients. Cefepime and imipenem were more active than ceftazidime and ceftriaxone against these organisms. Only vancomycin demonstrated reliable activity against oxacillin-resistant staphylococci, Enterococcus spp., and Corynebacterium spp. The spectrum of gram-positive organisms against which cefepime and imipenem have activity provides an advantage over ceftazidime as empiric therapy for cancer patients, potentially reducing the need for the empiric addition of glycopeptides.
Details
- Title: Subtitle
- Comparison of activities of broad-spectrum beta-lactam compounds against 1,128 gram-positive cocci recently isolated in cancer treatment centers
- Creators
- Daniel J Diekema - Department of Pathology, University of Iowa College of Medicine, Iowa City 52242, USA. daniel-diekema@uiowa.eduStacy L CoffmanSteven A MarshallMondell L BeachKenneth V I RolstonRonald N Jones
- Resource Type
- Journal article
- Publication Details
- Antimicrobial agents and chemotherapy, Vol.43(4), pp.940-943
- Publisher
- United States
- DOI
- 10.1128/AAC.43.4.940
- PMID
- 10103204
- PMCID
- PMC89230
- ISSN
- 0066-4804
- eISSN
- 1098-6596
- Language
- English
- Date published
- 04/1999
- Academic Unit
- Infectious Diseases; Pathology; Internal Medicine
- Record Identifier
- 9983986364702771
Metrics
17 Record Views